(Q40519206)

21 September 2017

1 reference

title

Clinicopathologic correlations of the antiphospholipid syndrome (English)

1 reference

21 September 2017

author

Ricard Cervera i Segura

series ordinal

1

object named as

Cervera R

1 reference

21 September 2017

2

Asherson RA

1 reference

21 September 2017

Lie JT

3

1 reference

21 September 2017

publication date

1 February 1995

1 reference

Seminars in Arthritis and Rheumatism

21 September 2017

published in

1 reference

21 September 2017

volume

24

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

262-272

1 reference

Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Hepatic infarction in a patient with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Skin lesions associated with circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Addison's disease, hypertension, renal and hepatic microthrombosis in 'primary' antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Bilateral adrenal infarction, hypoadrenalism and splinter haemorrhages in the 'primary' antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome--a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Thromboembolism in patients with the 'lupus'-type circulating anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Acute adrenal insufficiency as a manifestation of the anticardiolipin syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Adrenal insufficiency in two women with anticardiolipin antibodies. Cause and effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Bilateral massive adrenal hemorrhage: early recognition and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Acute adrenal insufficiency and the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

1 reference

7 January 2021

The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Pulmonary hypertension in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Sneddon's syndrome: an antiphospholipid antibody syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Neurological disease associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Cerebral venous thrombosis with lupus anticoagulants. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Findings at necropsy in the heart of a patient with anticardiolipin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Optic neuritis and myelopathy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

The Prosser-White oration 1983. Connective tissue disease and the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

The spectrum of livedo reticularis and anticardiolipin antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Clinical and immunologic features of livedo reticularis in lupus: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus erythematosus and lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Gangrene as a manifestation of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

PERIPHERAL VASCULAR SYNDROMES ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

CUTANEOUS MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Cutaneous necrosis associated with the lupus anticoagulant.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Widespread cutaneous necrosis associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

The lupus coagulation inhibitor and venous thrombosis: a report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Amaurosis fugax associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Discoid lupus erythematosus associated with the anticardiolipin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

CNS involvement in malignant atrophic papulosis (Kohlmeier-Degos disease): vasculopathy and coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Antiphospholipid antibody syndrome with right atrial thrombosis mimicking an atrial myxoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Valvular heart disease in the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Pregnancy and antibodies to phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Antiphospholipid antibodies in unselected patients with repeated abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

The antiphospholipid syndrome: a syndrome in evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Induction of Experimental Primary and Secondary Antiphospholipid Syndromes in Naive Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

Renal infarction associated with anti-phospholipid antibodies in systemic lupus erythematosus and "lupus-like" disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980036-0

7 January 2021

10.1016/S0049-0172(95)80036-0

Identifiers

DOI

1 reference

21 September 2017

1 reference